4Wallace JM, Bhattacharya S, Campbell DM, et al. Inter- pregnancy weight change impacts placental weight and is associated with the risk of adversepregnancy out- comes in the second pregnancy [J]. BMC Pregnancy Childbirth, 2014,22(14) :40.
5Shekhar S, Sharma C, Thakur S, et al. Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial[J]. Obstet Gyneeol, 2013,122(5) . 1057-1063.
6EL-Shafey EM’EL-Nagar GF, Selim MF,et al. Is serumcystatin C an accurate endogenous marker of glomerularfiltration rate for detection of early renal impairment in pa-tients with type 2 diabetes mellitus [J]. Ren Fail,2009,31(5):355-359.
7Eldolah Y’Karumanchi SA,Sachs BP. Recent advances in un-derstanding of preeclampsia [J]. Croat Med J,2005,46(5):728-736.
8Cahill PA, Redmond EM, Sitzmann JV. Endothelial dys-function in cirrhosis and portal hypertension [J]. Pharma-cology & Therapeutics,2001,89(3) :273-293.
9Harshita RB. Study of predisposing and associated risk fac-tors with pregnancy induced hypertension(PlH) in women atrural hospital [J]. Australas Med J,2013,6(4) ;231-232.
10Strevens H, Wide-Swensson D,Torffvit 0,et al. Serum cys-tatin C for assessments of glomerular filtration rate in preg-nant and non-pregnant women [J]. Scand J Clin Lab Invest,2002,62(2):141-147.
